Expression and tissue localization of membrane-types 1, 2, and 3 matrix metalloproteinases in human urothelial carcinomas

Journal of Urology

Volumn 160, Issue 4, 1998, Pages 1540-1545

  Kitagawa, Yasuhide ^b   Kunimi, Kazuto ^a   Ito, Hideaki ^b   Sato, Hiroshi ^b   Uchibayashi, Tadao ^b   Okada, Yasunori ^b   Seiki, Motoharu ^b   Namiki, Mikio ^b  

^a KANAZAWA UNIV SCHOOL OF MEDICINE   (Japan)

^b NONE

Author keywords

Membrane type matrix metalloproteinase; Urothelial carcinoma

Indexed keywords

COLLAGENASE; GELATINASE A; MESSENGER RNA; MONOCLONAL ANTIBODY; PHOSPHORUS 32; STROMELYSIN;

ARTICLE; CANCER INVASION; CONTROLLED STUDY; ENZYME LOCALIZATION; EXTRACELLULAR MATRIX; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; IMMUNOHISTOCHEMISTRY; METASTASIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SOUTHERN BLOTTING; TRANSITIONAL CELL CARCINOMA; UROGENITAL TRACT TUMOR; UROTHELIUM;

EID: 0032322527     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(01)62609-0     Document Type: Article

References (25)

1. Matrisian, L. M.: Metalloproteinases and their inhibitors in matrix remodeling. Trends Genet., 6: 121, 1990.
2. Mignatti, P. and Rifkin, D. B.: Biology and biochemistry of proteinases in tumor invasion. Physiol. Rev., 73: 161, 1993.
3. Stetler-Stevenson, W. G., Aznavoorian, S. and Liotta, L. A.: Tumor cell interactions with the extracellular matrix during invasion and metastasis. Ann. Rev. Cell Biol., 9: 541, 1993.
4. Atkinson, S. J., Ward, R. V., Reynolds, J. J. and Murphy, G.: Cell-mediated degradation of type collagen and gelatin films is dependent on the activation of matrix metalloproteinase. Biochem. J., 194: 721, 1990.
5. Strongin, A. Y., Marmer, B. L., Grant, G. A. and Goldberg, G. I.: Plasma membrane-dependent activation of 72 kDa type collagenase is prevented by complex formation with TIMP-2. J. Biol. Chem., 268: 14033, 1993.
6. Sato, H., Takino, T., Okada, Y., Cao, J., Shinagawa, A., Yamamoto, E. and Seiki, M.: A matrix metalloproteinase expressed on the surface of invasive tumor cells. Nature (Lond. ), 370: 61, 1994.
7. Will, H. and Hinzmann. B.: cDNA sequence and mRNA tissue distribution of a novel human matrix metalloproteinase with a potential transmembrane segment. Eur. J. Biochem., 231: 602, 1995.
8. Takino, T., Sato, H., Sinagawa, A. and Seiki, M., Identification of the second membrane-type matrix metalloproteinase (MT-MMP-2) gene from a human placenta cDNA library. J. Biol. Chem., 270: 23013, 1995.
9. Nomura, H., Sato, H., Seiki, M., Mai, M. and Okada, Y.: Expression of membrane type matrix metalloproteinase in human gastric carcinomas. Cancer Res., 55: 3263, 1995.
10. Tokuraku, M., Sato, H., Murakami, S., Okada, Y., Watanabe, Y. and Seiki, M.: Activation of the precursor of gelatinase A/72 kDa type collagenase/MMP-2 in lung carcinomas correlates with expression of membrane-type matrix metalloproteinase (MT-MMP) and lymph node metastasis. Int. J. Cancer., 64: 355, 1995.
11. Ueno, H., Nakamura, H., Inoue, M., Imai, K., Noguchi, M., Sato, H., Seiki, M. and Okada, Y.: Expression and tissue localization of membrane-types 1, 2 and 3 matrix metalloproteinases in human invasive breast carcinomas. Cancer Res., 57: 2055, 1997.
12. Yamamoto, M., Mohanam, S., Sawaya, R., Fuller, G. N., Seiki, M., Sato, H., Gokaslan, Z. L., Liotta, L. A,. Nicolson, G. L. and Rao, J. S.: Differential expression of membrane-type matrix metalloproteinase and its correlation with gelatinase A activation in human malignant brain tumors in vivo and in vitro. Cancer Res., 56: 384, 1996.
13. Okada, A., Bellocq, J. P., Rouyer, N., Chenard, M. P., Rio, M. C., Chambon, P. and Basset, P.: Membrane-type matrix metalloproteinase (MT-MMP) gene is expressed in stromal cells of human colon, breast, and head and neck carcinomas. Proc. Natl. Acad. Sci. USA, 92: 2730, 1995.
14. Yoshizaki, T., Sato, H., Maruyama, Y., Murono, S., Furukawa, M., Park, C. and Seiki, M.: Increased expression of membrane type 1-matrix metalloproteinase in head and neck carcinoma. Cancer, 79: 139, 1997.
15. Davies, B., Waxman, J., Wasan, H., Abel, P., Williams, G., Krautsz, T., Neal, D., Thomas, D., Hanby, A. and Balkwill, F.: Levels of matrix metalloproteinases in bladder cancer correlate with tumor grade and invasion. Cancer Res., 53: 5365, 1993.
16. Mostofi, F., Sobin, L. and Torloni, H.: Histological Typing of Urinary Bladder Tumours. Geneva: World Health Organization, 1973.
17. Hermanek, P., Sobin, L.: International Union Against Cancer: TNM Classification of Malignant Tumors. 4th ed. Berlin: Springer-Verlag, 1987.
18. Ng, S., Gunning, P., Eddy, R., Ponte, P., Leavitt, J., Shows, T. and Kedes, L.: Evolution of the functional human β-actin gene and its multi-pseudogene family: conservation of noncoding regions and chromosomal dispersion of pseudogenes. Mol. Cell. Biol., 5: 2720, 1985.
19. Tanaka, M., Sato, H., Takino, T., Iwata, K., Inoue, M. and Seiki, M.: Isolation of a mouse MT2-MMP gene from a lung cDNA library and identification of its product. FEBS Lett., 402: 219, 1997.
20. Murphy, L. D., Herzog, C. E., Rudick, J. B., Fojo, A. T. and Bates, S. E.: Use of the polymerase chain reaction in the quantitation of mdr-1 gene expression. Biochemistry, 29: 10351, 1990.
21. Hicks, R. M.: Multistage carcinogenesis in the urinary bladder. Br. Med. Bull., 36: 39, 1980.
22. Wolf, H. and Hojgaard, K.: Urothelial dysplasia concomitant with bladder tumours as a determinant factor for future new occurrences. Lancet, 2: 134, 1983.
23. Sidranski, D., Frost, P., Eschenbach, A. V., Oyasu, R., Preisinger, A. C. and Vogelstein, B.: Clonal origin of bladder cancer. N. Engl. J. Med., 326: 737, 1992.
24. Lunec, J., Challen, C., Wright, C., Mellon, K. and Neal, D. E.: C-erb-2 amplification and identical p53 mutations in concomitant transitional carcinomas of renal pelvis and urinary bladder. Lancet, 339: 439, 1992.
25. Takeichi, M.: Cadherin cell adhesion receptors as a morphogenetic regulator. Science, 251: 1451, 1991.